“…The HSV-2 isolates were selected retrospectively from viral isolates obtained in cell culture and stored in the laboratory between 2005 and 2012, in order to obtain a range of viruses collected from both immunocompetent and immunosuppressed (mainly HIV-infected) patients and recovered from different body sites (i.e., anal, genital, buttock, ear, bronchoalveolar lavage fluid, and back specimens). This selection allowed comparison of isolates from epidemiologically unrelated patients (isolates 1 to 43), sequential isolates corresponding to recurrent episodes in the same individuals, for which resistance to antivirals was investigated (isolates 44 to 46), and isolates recently described and belonging to a new HSV-2 genetic variant (designated HSV-2v; isolates 47 to 50) (20). All HSV-2 isolates were recovered from patients originating from European countries (mainly France) except for isolates 47 to 50, which were obtained from patients from West Africa (20).…”